NDA 012382 · Hikma
Largon
Propiomazine Hydrochloride · Injection
NovelDiscontinuedLast checked: Nov 20, 2026Latest source record: Aug 5, 1994 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1960
Dec 5, 1960
Approved uses
1
Original approval plus efficacy supplements
Registered trials
0
0 Phase 3, 0 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Dec 5, 1960 Original approval · Type 1 - New Molecular Entity
1 products under this application
- LARGON · PROPIOMAZINE HYDROCHLORIDE 20MG/ML · INJECTABLE, INJECTION · Discontinued
Clinical trials
Interventional ClinicalTrials.gov studies with "Propiomazine" as an intervention, any sponsor and status, largest first.
No registered drug trials name this ingredient.
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Phenothiazine analgesia--fact or fantasy?
McGee JL, Alexander MR · Am J Hosp Pharm 1979 · Clinical Trial, Controlled Clinical Trial
- A comparison of zopiclone and propiomazine as hypnotics in outpatients: a multicentre, double-blind, randomized, parallel-group comparison of zopiclone and propiomazine in insomniacs.
Dehlin O, Bengtsson C, Rubin B · Curr Med Res Opin 1997 · Clinical Trial, Comparative Study
- Propiomazine, pentobarbital, hydroxyzine, and placebo: double-blind comparison of sedative effects.
Elliott HW, Fisher CW, de Lappe A, et al. · Anesthesiology 1969 · Clinical Trial, Comparative Study
- Effects of propiomazine on respiration and circulation.
Markello R, King BD · Anesthesiology 1966 · Clinical Trial
- Effects of single doses of propiomazine, a phenothiazine hypnotic, on sleep and oxygenation in patients with stable chronic obstructive pulmonary disease.
Midgren B, Hansson L, Ahlmann S, et al. · Respiration 1990 · Clinical Trial, Comparative Study
- A comparison of meperidine and propiomazine hydrochloride when employed to produce quietude during regional anesthesia.
Albritton JT, Dornette WH · J Tenn Med Assoc 1966 · Case Reports, Clinical Trial
Sponsor: Hikma
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.